This work has been retracted.
Statement of Retraction: HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress
Year: 2026
Type: retraction
Abstract: We, the Editors and Publisher of the journal Bioengineered, have retracted the following article from publication.Chen, D., Ruan, X., Liu, Y., & He, Y. (2022). HMGCS2 silencing attenuates high gluc...
Source: Bioengineered
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,864
OpenAlex ID: W7215110282